SynBiotic SE Stock

Equities

SBX

DE000A3E5A59

Pharmaceuticals

End-of-day quote BOERSE DUESSELDORF 06:00:00 2024-04-25 pm EDT 5-day change 1st Jan Change
9.5 EUR +4.17% Intraday chart for SynBiotic SE -5.00% +217.73%
Sales 2023 * 14.4M 15.4M Sales 2024 * 17.1M 18.28M Capitalization 44.46M 47.54M
Net income 2023 * -2M -2.14M Net income 2024 * - 0 EV / Sales 2023 * 3.12 x
Net Debt 2023 * 500K 535K Net Debt 2024 * 3.1M 3.31M EV / Sales 2024 * 2.78 x
P/E ratio 2023 *
-22.6 x
P/E ratio 2024 *
-106 x
Employees 104
Yield 2023 *
-
Yield 2024 *
-
Free-Float 100%
More Fundamentals * Assessed data
Dynamic Chart
1 day+4.17%
1 week-5.00%
Current month-21.81%
1 month-22.45%
3 months+133.99%
6 months+148.04%
Current year+217.73%
More quotes
1 week
8.92
Extreme 8.92
10.40
1 month
8.92
Extreme 8.92
13.35
Current year
3.13
Extreme 3.13
16.35
1 year
2.89
Extreme 2.89
16.35
3 years
2.89
Extreme 2.89
43.00
5 years
1.05
Extreme 1.05
43.00
10 years
1.05
Extreme 1.05
43.00
More quotes
Managers TitleAgeSince
Chief Executive Officer - 23-08-20
Director of Finance/CFO - 22-12-31
Chief Tech/Sci/R&D Officer - -
Members of the board TitleAgeSince
Director/Board Member - -
More insiders
Date Price Change Volume
24-04-26 9.5 +4.17% 250
24-04-25 9.12 -0.87% 250
24-04-24 9.2 -9.36% 195

End-of-day quote BOERSE DUESSELDORF, April 25, 2024

More quotes
SynBiotic SE is a Germany-based investment company. Mainly the Company invests in cannabinoid focused ventures and teams.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
9.5 EUR
Average target price
15.2 EUR
Spread / Average Target
+60.00%
Consensus

Annual profits - Rate of surprise